CFD-d on keerulised instrumendid, millega kaasneb võimenduse tõttu suur risk kiiresti raha kaotada. 84% jaeinvestoritest kaotab selle pakkuja juures CFD-dega kaubeldes raha. Mõelge järele, kas mõistate CFD-de toimimise põhimõtet ja kas saate endale lubada riski rahast ilma jääda.

Scan to Download iOS&Android APP

Ost-müük Coherus BioSciences - CHRS CFD

7.37
0.14%
  • Kokkuvõte
  • Ajaloolised andmed
  • Sündmused
  • Tuluaruanne
  • Bilanss
  • Rahavood
  • Omand
Kauplemistingimused
Hinnavahe 0.07
Pika positsiooni ööpäeva tasu

Long position overnight fee


Margin. Your investment $1,000.00
Üleöö tasu -0.030779 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Mine platvormile
-0.030779%
Lühikese positsiooni ööpäeva tasu

Short position overnight fee


Margin. Your investment $1,000.00
Üleöö tasu -0.013666 %
Charges from borrowed part ($-0.55)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Mine platvormile
-0.013666%
Ööpäeva tasu aeg 22:00 (UTC)
Min kauplemise kogus 1
Valuuta USD
Tagatis 20%
Aktsiabörs United States of America
Kauplemise vahendustasu 0%

*Information provided by Capital.com

Võtmestatistika
Eelmine sulgemine* 7.33
Avatud* 7.19
Aastane muutus* -2.44%
Päeva ulatus* 7.09 - 7.35
52 nädala ulatus 5.58-14.11
Keskmine maht (10 päeva) 818.32K
Keskmine maht (3 kuud) 26.24M
Turukapitalisatsioon 696.89M
P/E suhtarv -100.00K
Ringluses olevad aktsiad 77.78M
Tulu 239.06M
EPS -3.60
Dividendid (% kasumist) N/A
Beeta 0.88
Järgmine tuluaruande kuupäev Feb 15, 2023

Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Sulgemishind Change (%) Avamishind High Low
Jun 29, 2022 7.37 0.30 4.24% 7.07 7.38 7.07
Jun 28, 2022 7.33 -0.24 -3.17% 7.57 7.70 7.21
Jun 27, 2022 7.61 0.13 1.74% 7.48 7.72 7.34
Jun 24, 2022 7.47 0.03 0.40% 7.44 7.63 7.19
Jun 23, 2022 7.35 0.71 10.69% 6.64 7.37 6.63
Jun 22, 2022 6.67 0.40 6.38% 6.27 6.92 6.27
Jun 21, 2022 6.60 0.30 4.76% 6.30 6.78 6.30
Jun 17, 2022 6.27 0.35 5.91% 5.92 6.31 5.89
Jun 16, 2022 5.85 0.11 1.92% 5.74 5.90 5.58
Jun 15, 2022 5.96 0.06 1.02% 5.90 6.12 5.81
Jun 14, 2022 5.97 -0.12 -1.97% 6.09 6.18 5.87
Jun 13, 2022 6.16 -0.32 -4.94% 6.48 6.55 6.09
Jun 10, 2022 6.69 -0.48 -6.69% 7.17 7.17 6.69
Jun 9, 2022 7.29 -0.30 -3.95% 7.59 7.73 7.27
Jun 8, 2022 7.70 0.25 3.36% 7.45 7.89 7.45
Jun 7, 2022 7.69 0.39 5.34% 7.30 7.72 7.30
Jun 6, 2022 7.55 -0.03 -0.40% 7.58 7.69 7.28
Jun 3, 2022 7.53 0.20 2.73% 7.33 7.72 7.33
Jun 2, 2022 7.42 0.18 2.49% 7.24 7.44 6.98
Jun 1, 2022 7.32 0.13 1.81% 7.19 7.41 7.06

Coherus BioSciences Events

Time (UTC) Country Event
No events scheduled
View all events
  • Aastas
  • Kvartalis
2016 2017 2018 2019 2020 2021
Kogutulu 190.106 1.556 0 356.071 475.824 326.551
Tulu 190.106 1.556 0 356.071 475.824 326.551
Kogu tegevuskulu 306.037 233.692 204.416 248.303 319.505 590.409
Müük/Üldine/admin kulud, kokku 51.597 71.303 94.177 137.037 139.079 169.713
Uuringud ja arendus 254.44 162.389 110.239 94.188 142.759 363.105
Tulud majandustegevusest -115.931 -232.136 -204.416 107.768 156.319 -263.858
Intressitulud (kulu), muud tulud, neto -7.98 -9.552 -9.684 -17.601 -21.166 -22.959
Muud, neto -3.877 3.402 4.691 2.608 0.554 -0.283
Netotulu enne makse -127.788 -238.286 -209.409 92.775 135.707 -287.1
Netotulu pärast makse -127.788 -238.286 -209.409 89.833 132.244 -287.1
Vähemuse intress 0.451 0.116 0.07 0 0
Netotulu enne erikulusid -127.337 -238.17 -209.339 89.833 132.244 -287.1
Netotulu -127.337 -238.17 -209.339 89.833 132.244 -287.1
Arvestatav tulu, v a erikulud -127.337 -238.17 -209.339 89.833 132.244 -287.1
Arvestatav tulu, koos erikuludega -127.337 -238.17 -209.339 89.833 132.244 -287.1
Jaotamisele kuuluv netotulu -127.337 -238.17 -209.339 89.833 135.551 -287.1
Keskmine jaotamisele kuuluv aktsia kohta 41.9123 53.1336 65.0348 73.1859 83.4919 75.4496
Jaotatav EPS, v a erakorralised kulud -3.03818 -4.48247 -3.21888 1.22746 1.62352 -3.80519
Jaotamisele kuuluv normaal-EPS -3.03818 -4.47118 -3.15891 1.22879 1.62352 -3.80519
Erakorralised kulud kokku 0
Kulud, Kokku 17.078 37.667 57.591
Brutokasum 338.993 438.157 268.96
Jaotuse korrigeerimine 3.307
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Kogutulu 83.034 87.643 82.503 73.371 60.115
Tulu 83.034 87.643 82.503 73.371 60.115
Kulud, Kokku 7.511 16.696 21.28 12.104 9.37
Brutokasum 75.523 70.947 61.223 61.267 50.745
Kogu tegevuskulu 250.394 111.807 115.29 112.918 147.262
Müük/Üldine/admin kulud, kokku 39.391 40.345 39.925 50.052 48.753
Uuringud ja arendus 203.492 54.766 54.085 50.762 82.917
Tulud majandustegevusest -167.36 -24.164 -32.787 -39.547 -87.147
Intressitulud (kulu), muud tulud, neto -5.648 -5.747 -5.771 -5.793 -8.969
Muud, neto 0.061 0.011 0.03 -0.385 0.032
Netotulu enne makse -172.947 -29.9 -38.528 -45.725 -96.084
Netotulu pärast makse -172.947 -29.9 -38.528 -45.725 -96.084
Netotulu enne erikulusid -172.947 -29.9 -38.528 -45.725 -96.084
Netotulu -172.947 -29.9 -38.528 -45.725 -96.084
Arvestatav tulu, v a erikulud -172.947 -29.9 -38.528 -45.725 -96.084
Arvestatav tulu, koos erikuludega -172.947 -29.9 -38.528 -45.725 -96.084
Jaotamisele kuuluv netotulu -172.947 -29.9 -38.528 -45.725 -96.084
Keskmine jaotamisele kuuluv aktsia kohta 72.8329 75.5597 79.0132 76.8441 77.2537
Jaotatav EPS, v a erakorralised kulud -2.37457 -0.39571 -0.48761 -0.59504 -1.24375
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Jaotamisele kuuluv normaal-EPS -2.37457 -0.39571 -0.48761 -0.59504 -1.16321
Ootamatud kulutused (tulu) 6.222
  • Aastas
  • Kvartalis
2016 2017 2018 2019 2020 2021
Käibevarad kokku 161.486 145.477 84.433 343.009 767.479 602.323
Raha ja lühiajalised investeeringud 124.947 126.911 72.356 177.668 541.158 417.195
Raha ja ekvivalendid 124.947 126.911 72.356 177.668 541.158 417.195
Laekumata arved, neto 1.859 0 141.992 157.046 123.022
Prepaid Expenses 31.634 18.364 10.285 13.542 25.042 24.464
Other Current Assets, Total 3.046 0.202 0.133 0
Total Assets 178.485 162.611 99.467 408.927 841.649 679.334
Property/Plant/Equipment, Total - Net 10.772 12.773 6.66 16.489 20.064 16.006
Property/Plant/Equipment, Total - Gross 16.798 22.575 19.697 32.785 36.114 32.855
Accumulated Depreciation, Total -6.026 -9.802 -13.037 -16.296 -16.05 -16.849
Goodwill, Net 0.943 0.943 0.943 0.943 0.943 0.943
Intangibles, Net 2.62 2.62 2.62 2.62 2.62 2.62
Other Long Term Assets, Total 2.664 0.798 4.811 45.866 50.543 57.442
Total Current Liabilities 56.376 28.395 33.261 114.969 145.653 165.327
Accounts Payable 19.706 15.481 15.294 25.985 15.201 16.159
Accrued Expenses 24.48 8.54 17.548 88.984 129.164 148.427
Notes Payable/Short Term Debt 0 0 0 0 0 0
Other Current Liabilities, Total 12.19 4.374 0.419 0.728
Total Liabilities 157.958 130.787 138.058 303.713 560.675 581.608
Total Long Term Debt 100.256 101.608 103.092 178.386 404.898 408.778
Long Term Debt 100.256 101.608 103.092 178.386 404.023 408.28
Minority Interest -1.173 -1.289 0
Other Liabilities, Total 2.499 2.073 1.705 10.358 10.124 7.503
Total Equity 20.527 31.824 -38.591 105.214 280.974 97.726
Common Stock 0.005 0.006 0.007 0.007 0.007 0.007
Additional Paid-In Capital 558.474 808.06 946.515 1000.76 1043.99 1147.84
Retained Earnings (Accumulated Deficit) -537.322 -775.492 -984.831 -894.998 -762.754 -1049.85
Other Equity, Total -0.63 -0.75 -0.282 -0.558 -0.27 -0.27
Total Liabilities & Shareholders’ Equity 178.485 162.611 99.467 408.927 841.649 679.334
Total Common Shares Outstanding 45.8082 59.8405 68.3027 70.3667 72.5134 76.9301
Total Inventory 1.659 9.807 44.233 37.642
Accounts Receivable - Trade, Net 141.992 157.046 123.022
Current Port. of LT Debt/Capital Leases 0.56 0.741
Capital Lease Obligations 0.875 0.498
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Käibevarad kokku 617.261 660.013 673.039 602.323 512.443
Raha ja lühiajalised investeeringud 399.503 454.421 468.707 417.195 325.68
Raha ja ekvivalendid 259.489 329.738 360.54 417.195 325.68
Lühiajalised investeeringud 140.014 124.683 108.167
Laekumata arved, neto 140.41 141.825 136.346 123.022 117.039
Accounts Receivable - Trade, Net 140.41 141.825 136.346 123.022 117.039
Total Inventory 51.613 39.668 37.583 37.642 36.945
Prepaid Expenses 25.735 24.099 30.403 24.464 32.779
Total Assets 693.303 739.542 741.726 679.334 593.387
Property/Plant/Equipment, Total - Net 19.1 18.03 8.505 16.006 7.998
Property/Plant/Equipment, Total - Gross 36.379 36.181 27.547 32.855 25.614
Accumulated Depreciation, Total -17.279 -18.151 -19.042 -16.849 -17.616
Goodwill, Net 0.943 0.943 0.943 0.943
Intangibles, Net 2.62 2.62 2.62 2.62 3.563
Other Long Term Assets, Total 53.379 57.936 56.619 57.442 69.383
Total Current Liabilities 257.601 287.052 320.348 165.327 153.748
Accounts Payable 15.482 14.568 45.707 16.159 21.092
Accrued Expenses 134.495 153.473 149.363 148.427 132.656
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 107.624 119.011 125.278 0.741
Total Liabilities 565.632 583.322 610.966 581.608 580.824
Total Long Term Debt 298.906 287.075 281.895 408.778 420.456
Long Term Debt 298.037 287.075 281.895 408.28 420.456
Capital Lease Obligations 0.869 0.498
Other Liabilities, Total 9.125 9.195 8.723 7.503 6.62
Total Equity 127.671 156.22 130.76 97.726 12.563
Common Stock 0.007 0.007 0.007 0.007 0.007
Additional Paid-In Capital 1063.67 1122.08 1135.16 1147.84 1158.77
Retained Earnings (Accumulated Deficit) -935.701 -965.601 -1004.13 -1049.85 -1145.94
Other Equity, Total -0.307 -0.267 -0.273 -0.27 -0.272
Total Liabilities & Shareholders’ Equity 693.303 739.542 741.726 679.334 593.387
Total Common Shares Outstanding 73.1229 76.4647 76.5833 76.9301 77.3382
  • Aastas
  • Kvartalis
2016 2017 2018 2019 2020 2021
Netotulu/algväärtus -127.788 -238.286 -209.409 89.833 132.244 -287.1
Raha majandustegevusest -252.545 -200.286 -159.266 28.355 154.145 -37.432
Raha majandustegevusest 2.996 3.398 3.235 3.259 2.888 3.454
Mittelikviidsed varad 31.461 39.735 36.611 49.191 51.067 203.266
Makstud intressid 6.939 8.2 8.2 15.263 16.959 18.684
Muutused tööjõus -159.214 -5.133 10.297 -113.928 -32.054 42.948
Tulu investeeringutelt -6.515 -4.417 -1.188 -12.732 -14.401 -138.41
Kapitalikulutused -6.515 -4.573 -0.789 -1.822 -7.231 -1.289
Muud rahavood investeeringutelt, kokku 0 0.156 -0.399 -10.91 -7.17 -137.121
Rahavood investeeringutelt 226.179 206.787 105.421 89.37 223.946 51.879
Rahavoogudesse investeerimine -0.705 -0.544 -0.815 -0.88 -1.753
Aktsiate emiteerimine (tagasiost), neto 127.623 207.331 105.421 17.23 21.229 54.304
Laenu väljastamine (kustutamine), neto 99.261 0 72.955 203.597 -0.672
Muutused valuutakursside kõikumisest -0.398 -0.12 0.468 -0.276
Rahaline kogumuutus -33.279 1.964 -54.565 104.717 363.69 -123.963
Cash Taxes Paid 1.732 3.953 1.221
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line -172.947 -202.847 -241.375 -287.1 -96.084
Cash From Operating Activities 1.367 1.179 14.89 -37.432 -54.045
Cash From Operating Activities 0.849 1.726 2.618 3.454 0.767
Non-Cash Items 166.9 171.468 190.497 203.266 58.389
Changes in Working Capital 6.565 30.832 63.15 42.948 -17.117
Cash From Investing Activities -285.475 -261.89 -245.9 -138.41 -35.615
Capital Expenditures -0.145 -0.56 -0.821 -1.289 -0.615
Other Investing Cash Flow Items, Total -285.33 -261.33 -245.079 -137.121 -35
Cash From Financing Activities 2.439 49.291 50.392 51.879 -1.855
Financing Cash Flow Items -1.89 -2.043 -2.222 -1.753 -2.839
Issuance (Retirement) of Stock, Net 4.329 51.334 52.614 54.304 0.544
Net Change in Cash -281.669 -211.42 -180.618 -123.963 -91.515
Issuance (Retirement) of Debt, Net 0 0 -0.672 0.44
Investori nimi Investori liik Ringluse protsent Hoitud osakud Muutus osakutes Hoidmise kuupäev Hinnang käibele
BlackRock Institutional Trust Company, N.A. Investment Advisor 14.3792 11183875 88569 2022-09-30 LOW
Temasek Holdings Pte. Ltd. Sovereign Wealth Fund 9.49 7381116 0 2022-09-30 LOW
AllianceBernstein L.P. Investment Advisor/Hedge Fund 7.8517 6106861 431412 2022-09-30 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 6.7052 5215182 350839 2022-09-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 6.5645 5105771 -1277332 2022-09-30 LOW
JP Morgan Asset Management Investment Advisor 5.5835 4342765 -188757 2022-09-30 LOW
Kohlberg Kravis Roberts & Co. L.P. Private Equity 3.9035 3036076 0 2022-09-30 LOW
Aristotle Capital Boston, LLC Investment Advisor 2.7532 2141380 -180788 2022-09-30 LOW
Medical Strategy GmbH Investment Advisor 2.3391 1819281 85000 2022-09-30 LOW
Perceptive Advisors LLC Private Equity 2.1434 1667123 -1978348 2022-09-30 LOW
Columbia Threadneedle Investments (US) Investment Advisor/Hedge Fund 2.032 1580477 -175396 2022-09-30 LOW
JPMorgan Asset Management U.K. Limited Investment Advisor/Hedge Fund 1.9029 1479999 -17637 2022-09-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.5804 1229209 32357 2022-09-30 LOW
Lanfear (Dennis M) Individual Investor 1.5152 1178502 75345 2023-01-20 LOW
Disciplined Growth Investors, Inc. Investment Advisor 1.4555 1132096 886075 2022-09-30 LOW
Peregrine Capital Management, LLC Investment Advisor 1.4368 1117482 -12124 2022-12-31 LOW
BlackRock Financial Management, Inc. Investment Advisor/Hedge Fund 1.3587 1056740 18831 2022-09-30 LOW
C WorldWide Asset Management Fondsmaeglerselskab A/S Investment Advisor 1.1937 928464 0 2022-09-30 LOW
Citi Investment Research (US) Research Firm 1.0771 837715 68015 2022-09-30 LOW
Balyasny Asset Management LP Hedge Fund 1.0285 799950 -278159 2022-09-30 HIGH

Miks valida Capital.com? Meie numbrid räägivad iseenda eest.

Capital.com Group
+485000+

Kauplejad

65000+

Igakuiste aktiivsete klientide arv

$48000000+

Igakuine investeerimise maht

$28000000+

Igakuiselt välja võetud

Kauplemiskalkulaator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Kauplemise vahendustasu
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Finantsvõimendus
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investeering
Tehingu suurus (võimendus x investeering):
Avamishind

Close

Lühike Pikk

Coherus BioSciences Company profile

Ettevõttest Coherus BioSciences

Coherus BioSciences, Inc. on kommertsjärgus biofarmatseutiline ettevõte. Ettevõte keskendub vähktõve raviks kasutatavate immunoteraapiate uurimisele, arendamisele ja turustamisele. See tegutseb inimtervishoius kasutatavate farmaatsiatoodete segmendi arendamise ja turustamisega. Ettevõtte tooteprogrammis on kolm tootekandidaati: toripalimab, PD-1-vastane antikeha, mida arendatakse koostöös Junshi Biosciences Co., Ltd.'ga, CIMERLI, Lucentise biosimilar-kandidaat, millele Bioeq on müügilitsentsi andnud Ameerika Ühendriikides ja Kanadas, ning bevatsizumabi (Avastin) biosimilar, millele Innovent Biologics (Suzhou) Co., Ltd. on müügilitsentsi andnud Ameerika Ühendriikides. Ettevõte arendab ka sisemist immunonkoloogilist tooteprogrammi prekliinilises ja translatiivses teaduses, bioinformaatikas, analüütilises iseloomustuses, protsessiteaduslikus tehnikas ning kliinilis-regulatiivses arendustegevuses ja turustamises.

Industry: Bio Therapeutic Drugs

C/O Dennis M. Lanfear
201 Redwood Shores Parkway, Suite 200
REDWOOD CITY
CALIFORNIA 94065
US

Tuluaruanne

  • Annual
  • Quarterly

Teised on vaadanud veel

BTC/USD

23,362.25 Price
-0.260% 1D Chg, %
Pika positsiooni ööpäeva tasu -0.0500%
Lühikese positsiooni ööpäeva tasu 0.0140%
Ööpäeva tasu aeg 22:00 (UTC)
Hinnavahe 60.00

Oil - Crude

73.41 Price
-3.570% 1D Chg, %
Pika positsiooni ööpäeva tasu -0.0223%
Lühikese positsiooni ööpäeva tasu 0.0065%
Ööpäeva tasu aeg 22:00 (UTC)
Hinnavahe 0.03

XRP/USD

0.41 Price
-0.340% 1D Chg, %
Pika positsiooni ööpäeva tasu -0.0500%
Lühikese positsiooni ööpäeva tasu 0.0140%
Ööpäeva tasu aeg 22:00 (UTC)
Hinnavahe 0.00283

US100

12,566.80 Price
-0.450% 1D Chg, %
Pika positsiooni ööpäeva tasu -0.0183%
Lühikese positsiooni ööpäeva tasu 0.0071%
Ööpäeva tasu aeg 22:00 (UTC)
Hinnavahe 3.0

Kas otsite jätkuvalt vahendajat, keda saab usaldada?

Ühinege 485,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com

1. Looge ja kinnitage oma konto 2. Tee sissemakse 3. Alusta kauplemist